SUVmax Above 20 in 18F-FDG PET/CT at Initial Diagnostic Workup Associates with Favorable Survival in Patients with Cancer of Unknown Primary.

IF 9.1 1区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Journal of Nuclear Medicine Pub Date : 2023-08-01 DOI:10.2967/jnumed.122.265161
Gregor Zaun, Manuel Weber, Martin Metzenmacher, Marcel Wiesweg, Thomas Hilser, Yasmin Zaun, Sven Liffers, Michael Pogorzelski, Isabel Virchow, Wilfried Eberhardt, Sarah Theurer, Tanja Abu Sabbah, Timm M Reissig, Martin Stuschke, Cornelius Kürten, Timon Hussain, Stephan Lang, Stefan Kasper, Wolfgang P Fendler, Ken Herrmann, Martin Schuler
{"title":"SUV<sub>max</sub> Above 20 in <sup>18</sup>F-FDG PET/CT at Initial Diagnostic Workup Associates with Favorable Survival in Patients with Cancer of Unknown Primary.","authors":"Gregor Zaun,&nbsp;Manuel Weber,&nbsp;Martin Metzenmacher,&nbsp;Marcel Wiesweg,&nbsp;Thomas Hilser,&nbsp;Yasmin Zaun,&nbsp;Sven Liffers,&nbsp;Michael Pogorzelski,&nbsp;Isabel Virchow,&nbsp;Wilfried Eberhardt,&nbsp;Sarah Theurer,&nbsp;Tanja Abu Sabbah,&nbsp;Timm M Reissig,&nbsp;Martin Stuschke,&nbsp;Cornelius Kürten,&nbsp;Timon Hussain,&nbsp;Stephan Lang,&nbsp;Stefan Kasper,&nbsp;Wolfgang P Fendler,&nbsp;Ken Herrmann,&nbsp;Martin Schuler","doi":"10.2967/jnumed.122.265161","DOIUrl":null,"url":null,"abstract":"<p><p>Cancer of unknown primary (CUP) is a heterogeneous entity with a limited prognosis. Novel prognostic markers are needed for patient stratification in prospective clinical trials exploring innovative therapies. <b>Methods:</b> In CUP patients treated at the West German Cancer Center Essen, the prognostic value of <sup>18</sup>F-FDG PET/CT at the initial diagnostic workup was analyzed by comparing overall survival (OS) in patients who underwent <sup>18</sup>F-FDG PET/CT with those who did not. <b>Results:</b> Of 154 patients with a CUP diagnosis, 76 underwent <sup>18</sup>F-FDG PET/CT at the initial diagnostic workup. The median overall survival (OS) of the full analysis set was 20.0 mo. Within the PET/CT subgroup, an SUV<sub>max</sub> above 20 was associated with significantly superior OS (median OS, not reached vs. 32.0 mo; hazard ratio, 0.261; 95% CI, 0.095-0.713; <i>P</i> = 0.009). <b>Conclusion:</b> Our retrospective work shows that an SUV<sub>max</sub> above 20 on <sup>18</sup>F-FDG PET/CT at the initial diagnostic workup is a favorable prognostic factor in patients with CUP. This finding deserves further prospective studies for validation.</p>","PeriodicalId":16758,"journal":{"name":"Journal of Nuclear Medicine","volume":"64 8","pages":"1191-1194"},"PeriodicalIF":9.1000,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Nuclear Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2967/jnumed.122.265161","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0

Abstract

Cancer of unknown primary (CUP) is a heterogeneous entity with a limited prognosis. Novel prognostic markers are needed for patient stratification in prospective clinical trials exploring innovative therapies. Methods: In CUP patients treated at the West German Cancer Center Essen, the prognostic value of 18F-FDG PET/CT at the initial diagnostic workup was analyzed by comparing overall survival (OS) in patients who underwent 18F-FDG PET/CT with those who did not. Results: Of 154 patients with a CUP diagnosis, 76 underwent 18F-FDG PET/CT at the initial diagnostic workup. The median overall survival (OS) of the full analysis set was 20.0 mo. Within the PET/CT subgroup, an SUVmax above 20 was associated with significantly superior OS (median OS, not reached vs. 32.0 mo; hazard ratio, 0.261; 95% CI, 0.095-0.713; P = 0.009). Conclusion: Our retrospective work shows that an SUVmax above 20 on 18F-FDG PET/CT at the initial diagnostic workup is a favorable prognostic factor in patients with CUP. This finding deserves further prospective studies for validation.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
初始诊断时18F-FDG PET/CT的SUVmax大于20与原发不明癌症患者的良好生存率相关。
原发性未知癌(CUP)是一种异质性的肿瘤,预后有限。在探索创新疗法的前瞻性临床试验中,需要新的预后标志物来进行患者分层。方法:在西德埃森癌症中心治疗的CUP患者中,通过比较接受18F-FDG PET/CT和未接受18F-FDG PET/CT的患者的总生存期(OS),分析18F-FDG PET/CT在初始诊断检查中的预后价值。结果:154例CUP诊断患者中,76例在初始诊断检查时接受了18F-FDG PET/CT检查。整个分析集的中位总生存期(OS)为20.0个月。在PET/CT亚组中,SUVmax高于20与显著优于OS相关(中位OS,未达到vs. 32.0个月;风险比0.261;95% ci, 0.095-0.713;P = 0.009)。结论:我们的回顾性研究表明,初始诊断时18F-FDG PET/CT上SUVmax大于20是CUP患者预后的有利因素。这一发现值得进一步的前瞻性研究来验证。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Nuclear Medicine
Journal of Nuclear Medicine 医学-核医学
CiteScore
13.00
自引率
8.60%
发文量
340
审稿时长
1 months
期刊介绍: The Journal of Nuclear Medicine (JNM), self-published by the Society of Nuclear Medicine and Molecular Imaging (SNMMI), provides readers worldwide with clinical and basic science investigations, continuing education articles, reviews, employment opportunities, and updates on practice and research. In the 2022 Journal Citation Reports (released in June 2023), JNM ranked sixth in impact among 203 medical journals worldwide in the radiology, nuclear medicine, and medical imaging category.
期刊最新文献
C-X-C Motif Chemokine Receptor 4-Directed Scintigraphy of Multiple Myeloma Using [99mTc]Tc-PentixaTec. Debating the Future of Nuclear Medicine: The Greek Experience. Peptide Receptor Radionuclide Therapy Is Effective for Clinical Control of Symptomatic Metastatic Insulinoma: A Long-Term Retrospective Analysis Identification of (R)-[18F]YH134 for Monoacylglycerol Lipase Neuroimaging and Exploration of Its Use for Central Nervous System and Peripheral Drug Development Value of68Ga-FAPI-04 and18F-FDG PET/CT in Early Prediction of Pathologic Response to Neoadjuvant Chemotherapy in Locally Advanced Gastric Cancer
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1